CN112107656A - Anticancer Chinese medicinal preparation and its preparation method - Google Patents
Anticancer Chinese medicinal preparation and its preparation method Download PDFInfo
- Publication number
- CN112107656A CN112107656A CN201910532883.3A CN201910532883A CN112107656A CN 112107656 A CN112107656 A CN 112107656A CN 201910532883 A CN201910532883 A CN 201910532883A CN 112107656 A CN112107656 A CN 112107656A
- Authority
- CN
- China
- Prior art keywords
- chinese medicinal
- herb
- preparation
- medicinal preparation
- anticancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 208000019425 cirrhosis of liver Diseases 0.000 claims abstract description 10
- 201000007270 liver cancer Diseases 0.000 claims abstract description 10
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 10
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 6
- 241000915604 Scutellaria barbata Species 0.000 claims abstract description 5
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 4
- 241001632409 Aralia elata Species 0.000 claims abstract description 4
- 235000015888 Aralia elata Nutrition 0.000 claims abstract description 4
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 4
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 4
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 4
- 241000758794 Asarum Species 0.000 claims abstract description 4
- 244000104272 Bidens pilosa Species 0.000 claims abstract description 4
- 235000010662 Bidens pilosa Nutrition 0.000 claims abstract description 4
- 244000146462 Centella asiatica Species 0.000 claims abstract description 4
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 4
- 241000221079 Euphorbia <genus> Species 0.000 claims abstract description 4
- 241001071795 Gentiana Species 0.000 claims abstract description 4
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 4
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 4
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 4
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 4
- 240000007171 Imperata cylindrica Species 0.000 claims abstract description 4
- 241001183967 Isodon Species 0.000 claims abstract description 4
- 241000244938 Penthorum chinense Species 0.000 claims abstract description 4
- 240000000103 Potentilla erecta Species 0.000 claims abstract description 4
- 235000016551 Potentilla erecta Nutrition 0.000 claims abstract description 4
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 4
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 206010008909 Chronic Hepatitis Diseases 0.000 claims description 3
- 241000711549 Hepacivirus C Species 0.000 claims description 3
- 241000709721 Hepatovirus A Species 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 208000006454 hepatitis Diseases 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 32
- 230000001976 improved effect Effects 0.000 abstract description 7
- 208000002672 hepatitis B Diseases 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 206010003445 Ascites Diseases 0.000 abstract description 3
- 208000004930 Fatty Liver Diseases 0.000 abstract description 3
- 206010016654 Fibrosis Diseases 0.000 abstract description 3
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 3
- 230000001476 alcoholic effect Effects 0.000 abstract description 3
- 230000007882 cirrhosis Effects 0.000 abstract description 3
- 208000010706 fatty liver disease Diseases 0.000 abstract description 3
- 230000002440 hepatic effect Effects 0.000 abstract description 3
- 208000005252 hepatitis A Diseases 0.000 abstract description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 15
- 238000011282 treatment Methods 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 9
- 238000002512 chemotherapy Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000011256 aggressive treatment Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anticancer Chinese medicinal preparation and a preparation method thereof, wherein the anticancer Chinese medicinal preparation is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb. The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.
Description
Technical Field
The invention relates to the technical field of anticancer preparation, in particular to an anticancer traditional Chinese medicine preparation and a preparation method thereof.
Background
Cancer is one of the most serious diseases endangering human health and is called absolute disease. Cancer is a life style disease, the cause of the disease is mostly internal and external mixed evil, and the gene mutation is caused by the combined action of the bad stimulation of external society, environment, psychology and other aspects on the basis of the disorder of human constitution, emotion, diet, life and other aspects, so as to cause the result of abnormal cell division. From the theory of syndrome differentiation of traditional Chinese medicine, the traditional Chinese medicine is formed by coagulation and cementation of various deficiency syndromes, qi stagnation, blood stasis, phlegm coagulation, heat toxin and other pathogens caused by the deficiency of vital qi of human bodies, is caused by unsmooth circulation of qi and blood of human bodies, is a local manifestation of systemic diseases, and can show different syndromes in different stages of different disease stages. The traditional Chinese medicine is used for treating cancer, and has the principles of clearing heat and removing toxicity, activating blood and dissolving stasis, dredging channels and collaterals, eliminating dampness and breaking hard mass, reinforcing primordial qi and consolidating the foundation and the like.
At present, the treatment methods of cancer mainly comprise operations, chemotherapy and radiotherapy in western medicine, and the methods play a positive role in the treatment of the cancer. However, extensive aggressive treatments such as radical enlargement, high dose chemotherapy and radiotherapy in surgery do not only serve to prolong the life of the patient, but also reduce the quality of life of the patient, aggravate the symptoms of the patient, such as digestive tract reactions (poor appetite, nausea, vomiting), bone marrow suppression (leukopenia, anemia), impaired organ function, and the like, and cause most patients to fail to adhere to and complete the treatment, and finally fail the treatment. The western medicine for cancer is provided with a plurality of medicines, but most of the medicines can only relieve symptoms, and the side effect is large. The problem of the liver cirrhosis precancerous lesion is that the clinical hot is the problem, and the treatment method for inhibiting the precancerous lesion by combining multiple disciplines is discussed, so that the curative effect can be greatly improved. The traditional Chinese medicine has the effects of improving the immunity of the organism and resisting cancer, the treatment is mainly based on the treatment methods of soothing the liver, promoting blood circulation, removing dampness by diuresis, detoxifying and removing food retention and the like at the early stage of liver cancer, the method is mainly based on strengthening the body resistance and consolidating the constitution at the middle and later stages, the method is mainly based on strengthening the spleen and replenishing qi, nourishing blood and softening the liver and nourishing yin and tonifying the kidney, the syndrome differentiation treatment embodies the individual treatment characteristics of the traditional Chinese medicine, and the traditional Chinese medicine has better curative effect on cause and syndrome. In addition, the traditional Chinese medicine is combined with chemotherapy, the respective advantages of the traditional Chinese medicine and the western medicine are brought into play, the adverse reaction of chemotherapy can be effectively prevented or alleviated, the patients can be ensured to successfully finish the chemotherapy treatment, the sensitivity of tumor cells to chemotherapy medicines can be increased, the tolerance of organisms to the chemotherapy is improved, the life quality is improved, the life cycle is prolonged, and the like.
In recent years, in China, people find that the cancer prevention and anticancer effect of the traditional Chinese medicine is better than that of a treatment method of western medicine, the pain of patients can be relieved, and the life quality of the patients can be improved.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an anticancer traditional Chinese medicine preparation and a preparation method thereof, wherein the anticancer traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
Preferably, the traditional Chinese medicine raw materials are soaked in mineral water with the volume 2-4 times of that of the traditional Chinese medicine raw materials for 2-3 hours.
Preferably, the traditional Chinese medicine raw materials except the rhubarb are boiled by strong fire after being soaked by mineral water, decocted by slow fire, and dregs are removed after the decoction to obtain juice; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
Preferably, the decoction is carried out in a way that the mass volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
Preferably, the method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCG) for resisting liver cancer and liver cirrhosis, and the administration is carried out 1 time respectively in the morning and at night.
Compared with the prior art, the invention has the beneficial effects that: the obtained anticancer Chinese medicine can improve immunity, inhibit the growth and diffusion of cancer cells, prevent cancer formation, treat various cancers, relieve and eliminate side effects caused by radiotherapy or chemotherapy, strengthen body constitution, and improve life quality of patients.
The main component of the invention is oldenlandia diffusa which is a yearly-raw and shavings herb, and the patent medicine is bitter and light in taste and cold in nature. Has the main effects of clearing away heat and toxic materials, relieving pain and dissipating stagnation, promoting blood circulation, inducing diuresis and removing dampness, and is especially good at treating various types of inflammation. In clinical practice, the compatibility of oldenlandia diffusa is found to be proper, which can cure various diseases.
The main component of the invention is the barbed skullcap herb which has the functions of clearing away heat and toxic material, promoting blood circulation by removing blood stasis and promoting urination. Belongs to heat-clearing and toxicity-removing herbs in the category of heat-clearing herbs. Has anticancer effect and has mild inhibition effect on blood cells of acute myelocytic leukemia (NvIL). Improving the function of an immune system, but inhibiting the thymus index of the mice by large-dose injection; has antibacterial effect; has strong effect of resisting smooth muscle contraction caused by histamine. Has good spasmolytic and phlegm eliminating effects. Has diuretic, respiratory stimulating, and snake venom expelling effects.
The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
An anticancer Chinese medicinal preparation and its preparation method, is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
In the invention, the traditional Chinese medicine raw materials are soaked in mineral water with 2-4 times of volume for 2-3 hours.
In the invention, the traditional Chinese medicine raw materials except rhubarb are boiled with strong fire after being soaked in mineral water, and then decocted with slow fire, and dregs are removed after decoction to obtain juice; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
In the invention, the decoction is specifically that the mass-volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
The method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCH) for resisting liver cancer and liver cirrhosis, and is taken 1 time in the morning and at night. The invention relates to a pure natural traditional Chinese medicine preparation, which is mainly used for liver cancer patients with hepatitis A, hepatitis B and hepatitis B, alcoholic liver, cirrhosis caused by fatty liver and hepatic ascites. The pain symptom of the patients is greatly relieved through the clinical administration of a plurality of patients, the living quality is improved, and the rehabilitation purpose is achieved.
The invention has the advantages that the invention totally adopts natural medicines, overcomes the toxic and side effects of synthetic medicines, carries out dialectical treatment according to the principle of strengthening body resistance and eliminating evil in traditional Chinese medicine, obviously improves the curative effect, has the total effective rate of 74 percent according to the observation of the curative effect of 50 patients, wherein 14 cases of significant effect (basic cure) account for 28 percent, and 23 cases of effective effect account for 46 percent, and is convenient to take and carry. It also has prophylactic and health promoting effects.
Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent substitutions, improvements, etc. within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (5)
1. An anticancer Chinese medicinal preparation and a preparation method thereof, which are characterized in that: the feed is prepared from the following raw materials in parts by weight: 15 g of linearstripe rabdosia herb, 15 g of oriental wormwood, 15 g of penthorum chinense pursh, 15 g of gentian, 15 g of radix bupleuri, 15 g of cogongrass rhizome, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of sticktight, 15 g of discolor cinquefoil herb, 15 g of ochronotus fulva, 15 g of heartleaf houttuynia herb, 15 g of garden balsam seed, 15 g of aralia elata, 15 g of sun euphorbia herb, 15 g of dandelion, 15 g of centella asiatica and 5 g of rhubarb.
2. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: soaking the above Chinese medicinal materials in 2-4 times of mineral water for 2-3 hr.
3. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: boiling the above Chinese medicinal materials except radix et rhizoma Rhei in mineral water, decocting with slow fire, and removing residue to obtain decoction; filtering, mixing filtrates, standing, collecting supernatant, concentrating into soft extract, drying under reduced pressure, and pulverizing into fine powder; pulverizing radix et rhizoma Rhei into fine powder; mixing the above dry extract powder and radix et rhizoma Rhei powder, granulating with ethanol, drying, and packaging.
4. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: the specific decocting method is that the mass volume ratio of the first decoction dregs to water is 1: 6-12 in g/mL.
5. The anticancer Chinese medicinal preparation and the preparation method thereof according to claim 1, wherein the anticancer Chinese medicinal preparation comprises the following raw materials: the method is suitable for patients with liver cancer and liver cirrhosis, and the hepatogenic causes include chronic hepatitis A and hepatitis C virus (HCH) for resisting liver cancer and liver cirrhosis, and is taken 1 time in the morning and at night.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910532883.3A CN112107656A (en) | 2019-06-19 | 2019-06-19 | Anticancer Chinese medicinal preparation and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910532883.3A CN112107656A (en) | 2019-06-19 | 2019-06-19 | Anticancer Chinese medicinal preparation and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112107656A true CN112107656A (en) | 2020-12-22 |
Family
ID=73795709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910532883.3A Pending CN112107656A (en) | 2019-06-19 | 2019-06-19 | Anticancer Chinese medicinal preparation and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112107656A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097621A (en) * | 1994-06-06 | 1995-01-25 | 郭文峰 | Anti-cancer powder |
-
2019
- 2019-06-19 CN CN201910532883.3A patent/CN112107656A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097621A (en) * | 1994-06-06 | 1995-01-25 | 郭文峰 | Anti-cancer powder |
Non-Patent Citations (1)
| Title |
|---|
| 隋鑫等: "中医防治原发性肝癌", 《实用中医内科杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103860699A (en) | Pharmaceutical composition for radically treating hypertension, hyperlipidemia and hyperglycemia | |
| CN101062368A (en) | Chinese traditional medicine for treating cirrhosis ascites | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN1436564A (en) | Liver cancer treating medicine and its prepn | |
| CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN104740583B (en) | It is a kind of to be used to alleviate Chinese medicine preparation of Crohn disease and preparation method thereof | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN101524470A (en) | Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102028831B (en) | Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof | |
| CN1152453A (en) | Medicine for curing chest rheumatism and pain and preparation method | |
| CN101204494B (en) | Medicine for chronic enteritis | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN112107656A (en) | Anticancer Chinese medicinal preparation and its preparation method | |
| CN1192922A (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN105944031A (en) | Anti-radiation traditional Chinese medicine and preparation method | |
| CN105232677A (en) | Traditional Chinese medicine composition for treating myocardial infarction and preparation method of traditional Chinese medicine composition | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN112494614A (en) | Chinese medicinal formula for preventing and treating cancer by using combination of pawpaw and various medicines | |
| CN104524535A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition | |
| CN104840891A (en) | Traditional Chinese medicine preparation used for treating alcoholic cardiomyopathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201222 |
|
| RJ01 | Rejection of invention patent application after publication |